Literature DB >> 2619377

Effect of albendazole in experimental toxocariasis of mice.

O Delgado1, C Botto, R Mattei, A Escalante.   

Abstract

Fifty-five mice were each infected with 800 embryonated eggs of Toxocara canis. Beginning on the second day of the infection, one group received a single 9 mg dose of albendazole every 24 hours for an eight-day period while a second group received 3 mg of albendazole every eight hours for the same period. On the tenth day of infection, mice in each treatment group and their corresponding controls were sacrificed, and the presence and motility of T. canis larvae in the brain were determined. With both therapeutical procedures the administration of albendazole reduced the number of larvae which reach the brain. However, for the same total dose, the administration of the drug every eight hours yielded results which were significantly superior to those produced by administering a single dose every 24 hours, reducing both the number of larvae in the brain and their motility.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2619377     DOI: 10.1080/00034983.1989.11812396

Source DB:  PubMed          Journal:  Ann Trop Med Parasitol        ISSN: 0003-4983


  2 in total

1.  Therapy and Prevention for Human Toxocariasis.

Authors:  Jean-François Magnaval; Emilie Bouhsira; Judith Fillaux
Journal:  Microorganisms       Date:  2022-01-22

2.  ANTHELMINTIC ACTIVITY OF LAPACHOL, β-LAPACHONE AND ITS DERIVATIVES AGAINST Toxocara canis LARVAE.

Authors:  Taís Mata-Santos; Nitza França Pinto; Hilton Antônio Mata-Santos; Kelly Gallan De Moura; Paula Fernandes Carneiro; Tatiane Dos Santos Carvalho; Karina Pena Del Rio; Maria do Carmo Freire Ribeiro Pinto; Lourdes Rodrigues Martins; Juliana Montelli Fenalti; Pedro Eduardo Almeida Da Silva; Carlos James Scaini
Journal:  Rev Inst Med Trop Sao Paulo       Date:  2015 May-Jun       Impact factor: 2.169

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.